X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-03-23 | CYRX | Sawicki Mark W | Chief Scientific Officer | S - Sale | $8.18 | -1,341 | 102,356 | -1% | -$10,969 | ||||||
| D | 2026-03-16 | CYRX | Sawicki Mark W | Chief Scientific Officer | S - Sale+OE | $8.00 | -3,235 | 103,697 | -3% | -$25,880 | |||||
2025-03-24 | CYRX | Sawicki Mark W | Chief Scientific Officer | S - Sale | $6.94 | -1,349 | 84,087 | -2% | -$9,364 | ||||||
| D | 2025-03-17 | CYRX | Sawicki Mark W | Chief Scientific Officer | S - Sale+OE | $6.29 | -2,092 | 85,436 | -2% | -$13,162 | |||||
| D | 2025-03-10 | CYRX | Sawicki Mark W | Chief Scientific Officer | S - Sale+OE | $4.88 | -1,583 | 78,528 | -2% | -$7,724 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |